A detailed history of J.Safra Asset Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, J.Safra Asset Management Corp holds 317 shares of LLY stock, worth $289,918. This represents 0.03% of its overall portfolio holdings.

Number of Shares
317
Previous 601 47.25%
Holding current value
$289,918
Previous $350,000 29.71%
% of portfolio
0.03%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $168,184 - $225,007
-284 Reduced 47.25%
317 $246,000
Q4 2023

Feb 02, 2024

SELL
$525.19 - $619.13 $42,015 - $49,530
-80 Reduced 11.75%
601 $350,000
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $211,539 - $248,442
681 New
681 $233,000
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $3,066 - $3,599
11 Added 12.79%
97 $0
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $20,183 - $25,082
86 New
86 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track J.Safra Asset Management Corp Portfolio

Follow J.Safra Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on J.Safra Asset Management Corp with notifications on news.